Table 4.
Later-line therapy | CR, n (%) | PR, n (%) | SD, n (%) | PD, n (%) | Response unknown, n (%) |
---|---|---|---|---|---|
Docetaxel (n = 13) | 0 (0.0) | 2 (15.4) | 1 (7.7) | 2 (15.4) | 8 (61.5) |
Paclitaxel (n = 26) | 1 (3.8) | 8 (30.8) | 8 (30.8) | 2 (7.7) | 7 (26.9) |
All (n = 39) | 1 (2.6) | 10 (25.6) | 9 (23.1) | 4 (10.3) | 15 (38.5) |
CR = Complete response, PR = partial response, SD = stable disease; PD = progressive disease.